IBDEI07X ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3565,0)
 ;;=V10.82^^33^281^58
 ;;^UTILITY(U,$J,358.3,3565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3565,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,3565,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,3565,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,3566,0)
 ;;=V10.02^^33^281^59
 ;;^UTILITY(U,$J,358.3,3566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3566,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,3566,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,3566,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,3567,0)
 ;;=V10.43^^33^281^60
 ;;^UTILITY(U,$J,358.3,3567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3567,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,3567,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,3567,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,3568,0)
 ;;=V10.46^^33^281^61
 ;;^UTILITY(U,$J,358.3,3568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3568,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,3568,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,3568,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,3569,0)
 ;;=V10.06^^33^281^62
 ;;^UTILITY(U,$J,358.3,3569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3569,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,3569,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,3569,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,3570,0)
 ;;=V10.52^^33^281^63
 ;;^UTILITY(U,$J,358.3,3570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3570,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,3570,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,3570,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,3571,0)
 ;;=V10.04^^33^281^65
 ;;^UTILITY(U,$J,358.3,3571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3571,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,3571,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,3571,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,3572,0)
 ;;=V10.47^^33^281^66
 ;;^UTILITY(U,$J,358.3,3572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3572,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,3572,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,3572,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,3573,0)
 ;;=V10.83^^33^281^64
 ;;^UTILITY(U,$J,358.3,3573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3573,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,3573,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,3573,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,3574,0)
 ;;=285.22^^33^281^6
 ;;^UTILITY(U,$J,358.3,3574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3574,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,3574,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,3574,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,3575,0)
 ;;=285.21^^33^281^8
 ;;^UTILITY(U,$J,358.3,3575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3575,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,3575,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,3575,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,3576,0)
 ;;=285.29^^33^281^7
 ;;^UTILITY(U,$J,358.3,3576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3576,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,3576,1,5,0)
 ;;=5^Anemia In Chronic Dis
 ;;^UTILITY(U,$J,358.3,3576,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,3577,0)
 ;;=284.9^^33^281^10
 ;;^UTILITY(U,$J,358.3,3577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3577,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,3577,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,3577,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,3578,0)
 ;;=282.61^^33^281^69
 ;;^UTILITY(U,$J,358.3,3578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3578,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,3578,1,5,0)
 ;;=5^Hemoglobin S Disease
